420 related articles for article (PubMed ID: 23578591)
21. Fn14 Deficiency Ameliorates Anti-dsDNA IgG-Induced Glomerular Damage in SCID Mice.
Wu J; Min X; Wang L; Yang J; Wang P; Liu X; Xia Y
J Immunol Res; 2018; 2018():1256379. PubMed ID: 30648117
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
[TBL] [Abstract][Full Text] [Related]
23. Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.
Serafini B; Magliozzi R; Rosicarelli B; Reynolds R; Zheng TS; Aloisi F
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1137-48. PubMed ID: 19018248
[TBL] [Abstract][Full Text] [Related]
24. TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice.
Son A; Oshio T; Kawamura YI; Hagiwara T; Yamazaki M; Inagaki-Ohara K; Okada T; Wu P; Iseki M; Takaki S; Burkly LC; Dohi T
Mucosal Immunol; 2013 Nov; 6(6):1131-42. PubMed ID: 23462911
[TBL] [Abstract][Full Text] [Related]
25. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
27. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
[TBL] [Abstract][Full Text] [Related]
28. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/
Huang MW; Stock AD; Mike EV; Herlitz L; Kolbeck R; Putterman C
Lupus; 2019 Nov; 28(13):1510-1523. PubMed ID: 31474191
[TBL] [Abstract][Full Text] [Related]
29. TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model.
Iacobas DA; Wen J; Iacobas S; Putterman C; Schwartz N
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440346
[TBL] [Abstract][Full Text] [Related]
30. Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice.
Gao HX; Sanders E; Tieng AT; Putterman C
J Neuroimmunol; 2010 Dec; 229(1-2):112-22. PubMed ID: 20800292
[TBL] [Abstract][Full Text] [Related]
31. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
[TBL] [Abstract][Full Text] [Related]
32. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
Huang MW; Stock AD; Putterman C
Front Immunol; 2021; 12():763065. PubMed ID: 34868008
[TBL] [Abstract][Full Text] [Related]
33. TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis.
Molano A; Lakhani P; Aran A; Burkly LC; Michaelson JS; Putterman C
Immunol Lett; 2009 Aug; 125(2):119-28. PubMed ID: 19573558
[TBL] [Abstract][Full Text] [Related]
34. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
Haile WB; Echeverry R; Wu J; Yepes M
J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
[TBL] [Abstract][Full Text] [Related]
35. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
[TBL] [Abstract][Full Text] [Related]
36. Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
Lu F; Lu H; Xie M; Li S; Zu Y; Zhou J; Yu J; Wang S; Ruan Y; Wen C; Xu Z
Inflammopharmacology; 2019 Jun; 27(3):511-520. PubMed ID: 30911862
[TBL] [Abstract][Full Text] [Related]
37. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
Echeverry R; Wu F; Haile WB; Wu J; Yepes M
J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
[TBL] [Abstract][Full Text] [Related]
38. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
[TBL] [Abstract][Full Text] [Related]
39. Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.
Stock AD; Wen J; Putterman C
Front Immunol; 2013 Dec; 4():484. PubMed ID: 24400009
[TBL] [Abstract][Full Text] [Related]
40. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
